全外显子组筛查识别重性抑郁障碍新罕见风险变异
研究利用英国生物银行200,643例全外显子组数据,经质控后纳入120,033例有MDD多基因风险评分(PRS)的参与者,筛选PRS最低30%者,以PHQ抑郁评分最高10%为病例、最低10%为对照,最终1612例病例和1612例对照纳入分析。基于MAF<0.01的34,761个合格变异进行单变异、基因负荷和稳健负荷检验,发现OR8B4基因rs4057749达全外显子组显著水平(P=5.39×10⁻⁹),基因负荷检验显示OR8B4、TRAPPC11、SBK3和TNRC6B与MDD相关。
要点
- 在低MDD PRS人群中识别出OR8B4基因罕见变异rs4057749与MDD在全外显子组水平显著相关(P=5.39×10⁻⁹)。
- 基因负荷检验显示OR8B4、TRAPPC11、SBK3和TNRC6B与MDD存在显著关联。
- 研究聚焦低PRS个体的罕见变异,有助于拓展MDD遗传病因学认识。
核心结论
- 在MDD多基因风险评分较低的个体中识别出多个贡献于MDD的新罕见风险变异,可拓展对MDD发病机制的遗传学认识。
研究设计与样本
- 利用英国生物银行200,643例全外显子组数据开展全外显子组关联研究,质控后纳入120,033例有MDD PRS值的参与者。
- 筛选PRS值最低30%分位者进行病例对照选择,以PHQ抑郁评分最高10%分位为病例、最低10%分位为对照,最终纳入1612例病例和1612例对照。
- 变异经ANNOVRA软件注释,排除后34,761个合格变异(包括148个移码、335个非移码、33,758个非同义、91个起始丢失、393个终止获得、36个终止丢失变异)导入SKAT R包,对MAF<0.01的变异进行单变异、基因负荷和稳健负荷检验。
主要发现
- 单变异关联检验在全外显子组显著水平识别出OR8B4基因内的rs4057749(P=5.39×10⁻⁹)。
- 基因负荷检验显示OR8B4与MDD全基因组显著相关(PSKAT=6.23×10⁻⁵,PSKAT Robust=4.49×10⁻⁵)。
- 基因负荷检验显示TRAPPC11(PSKAT=0.014,PSKAT Robust=0.015)、SBK3(PSKAT=0.020,PSKAT Robust=0.025)和TNRC6B(PSKAT=0.026,PSKAT Robust=0.036)与MDD相关。
关键数值与推荐
- 病例定义为PRS值最低30%分位人群中PHQ抑郁评分最高10%分位者,对照为最低10%分位者。
- 纳入分析的变异为MAF<0.01的34,761个合格变异。
- 单变异关联检验显著性阈值为全外显子组显著水平,rs4057749的P=5.39×10⁻⁹。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite thousands of common genetic loci of major depression disorders (MDD) have been identified by GWAS to date, a large proportion of genetic variation predisposing to MDD remains unaccounted for. By utilizing the newly released UK Biobank 200,643 exome dataset, we conducted an exome-wide association study to identify rare risk variants contributing to MDD. After quality control, 120,033 participants with MDD polygenic risk scores (PRS) values were included. The individuals with lower 30% quantile of the PRS value were filtered for case and control selecting. Then the cases were set as the individuals with upper 10% quantile of the PHQ depression score and lower 10% quantile were set as controls. Finally, 1612 cases and 1612 controls were included in this study. The variants were annotated by ANNOVRA software. After exclusions, 34,761 qualifying variants, including 148 frameshift variant, 335 non-frameshift variant, 33,758 nonsynonymous, 91 start-loss, 393 stop-gain, 36 stop-loss variants were imported into the SKAT R-package to perform single variants, gene-based burden and robust burden tests with minor allele frequency (MAF) < 0.01. Single variant association testing identified one variant, rs4057749 (P = 5.39 × 10-9), within OR8B4 gene at an exome-wide significance level. The gene-based burden test of the exonic variants identified genome-wide significant associations in OR8B4 (PSKAT = 6.23 × 10-5, PSKAT Robust = 4.49 × 10-5), TRAPPC11 (PSKAT = 0.014, PSKAT Robust = 0.015), SBK3 (PSKAT = 0.020, PSKAT Robust = 0.025) and TNRC6B (PSKAT = 0.026, PSKAT Robust = 0.036). We identified multiple novel rare risk variants contributing to MDD in the individuals with lower PRS of MDD. The findings can help to broaden the genetic insights of the MDD pathogenesis.
引用
- Cheng S, Cheng B, Liu L, et al. Exome-wide screening identifies novel rare risk variants for major depression disorder. Mol Psychiatry. 2022. PMID: 35365804. doi:10.1038/s41380-022-01536-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。